Since last few years, research and development of multiplex molecular diagnostics test in clinical microbiology have allowed many laboratories around the world to grow more rapidly and with ease. This has also helped many of these institution to analyze these pathogens directly using multiplex molecular diagnostics in clinical specimens. Above all, recent developments such as approval from USFDA to analyze multiple organisms in single run is helping the market of molecular diagnostic panels to flourish. Using multiplex molecular diagnostics tools, researchers and laboratory personals are able to identify most common laboratory pathogens in gastrointestinal and respiratory more effectively. The w respiratory viral, gastrointestinal, or central nervous system infections.
This report contains market size and forecasts of Multiplex Molecular Diagnostic in Global, including the following market information:
Global Multiplex Molecular Diagnostic Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Multiplex Molecular Diagnostic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Real-time PCR Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Multiplex Molecular Diagnostic include BD, bioMérieux, SpeeDx, Roche, Contextual Genomics, GenMark Diagnostics, Hologic, Luminex Corporation and Binx Health. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Multiplex Molecular Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Multiplex Molecular Diagnostic Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Multiplex Molecular Diagnostic Market Segment Percentages, by Type, 2021 (%)
Real-time PCR
Nested PCR with Melt Curve Analysis
PCR with Low density Microarray
PCR with Liquid Phase Bead Array
PCR with Electrochemical Detection
Global Multiplex Molecular Diagnostic Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Multiplex Molecular Diagnostic Market Segment Percentages, by Application, 2021 (%)
Clinical Research Laboratory
Hospitals
Academic and Research Centers
Others
Global Multiplex Molecular Diagnostic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Multiplex Molecular Diagnostic Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Multiplex Molecular Diagnostic revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Multiplex Molecular Diagnostic revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
BD
bioMérieux
SpeeDx
Roche
Contextual Genomics
GenMark Diagnostics
Hologic
Luminex Corporation
Binx Health